「news一般製品2022年11月10日」の検索結果
161件：131～135件目を表示
-
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
http://www.senju.co.jp/english/rd/ -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeLaunched（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye
http://www.senju.co.jp/english/rd/pipeline.html -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being.Today’s common sense may not be common sense tomorrow. At Senju Pharmaceutical, we are dedicated not only to our original R&D initiatives but also to R
http://www.senju.co.jp/english/rd/about/ -
Mytear ALPITATTO NEXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO NEXα Works on unbearable eye itching due to pollens and other
http://www.senju.co.jp/english/products/nex.html -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
Designated quasi-drugs Mytear® HARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable len
http://www.senju.co.jp/english/products/wettingsolution.html